Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Reactivation of Autophagy Through Spermidine on Venous Endothelial Function

NCT04138134 is registered in ClinicalTrials.gov with Neuromed IRCCS as lead sponsor.

NCT NCT04138134
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04138134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Reactivation of Autophagy Through Spermidine on Venous Endothelial Function
Lead sponsor
Neuromed IRCCS
Phase
Observational
Overall status
Unknown status
Start date
February 1, 2022
Completion date
April 1, 2023
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

venous disease